A protein kinase that appears to be well suited to controlling transcription and other nuclear events is DNA-dependent protein kinase (DNA-PK), an abundant enzyme in human cells that is located primarily within the nucleus (1-5). An important feature of DNA-PK is that it interacts with DNA and must be DNA-bound to be active. We and others (6-8) have shown that DNA-PK consists of two components. One, the catalytic component, is a protein of -350 kDa (p350). On its own, however, p350 is inactive and requires the second DNA-PK component to target it to DNA and trigger its kinase activity. This second component is human autoimmune antigen Ku, which is composed of two tightly associated polypeptides of approximately 70 and 80 kDa (Ku7O and Ku80, respectively).
repair and/or recombination. Consistent with this, Ku find that xrs-6 cells completely lack DNA-PK activity. By contrast, xrs-6 derivatives complemented by human chromosome fragments bearing the Ku8O gene have restored both the DNA end binding and kinase activities associated with DNA-PK. Finally, we show that xrs-6 extracts are complemented biochemically by purified Ku. Our findings indicate that the xrs-6 defects are direct consequences of the mutation in Ku80 and implicate DNA-PK in recombination and DNA repair processes.
A protein kinase that appears to be well suited to controlling transcription and other nuclear events is DNA-dependent protein kinase (DNA-PK), an abundant enzyme in human cells that is located primarily within the nucleus (1) (2) (3) (4) (5) . An important feature of DNA-PK is that it interacts with DNA and must be DNA-bound to be active. We and others (6) (7) (8) have shown that DNA-PK consists of two components. One, the catalytic component, is a protein of -350 kDa (p350). On its own, however, p350 is inactive and requires the second DNA-PK component to target it to DNA and trigger its kinase activity. This second component is human autoimmune antigen Ku, which is composed of two tightly associated polypeptides of approximately 70 and 80 kDa (Ku7O and Ku80, respectively).
Although in vivo targets for DNA-PK have not yet been defined unequivocally, many transcription factors, including Spl, c-Jun, c-Fos, p53, and CTF1/NF-I are phosphorylated by this enzyme in vitro (2, 3, 7, (9) (10) (11) . One function of DNA-PK may therefore be to control gene expression. However, since transcription factors can also influence nuclear events such as DNA replication, recombination, and DNA repair (12) (13) (14) (15) ,
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We and others (16) (17) (18) have shown recently that Ku DNA binding activity is absent in the Chinese hamster ovary cell line xrs-6, which is impaired in DNA double-strand break repair and V(D)J recombination (19) (20) (21) . The Ku8O gene maps to the region of human chromosome 2 containing the gene XRCC5, which complements the xrs-6 mutation (22) (23) (24) . Furthermore, we have demonstrated thatxrs-6 cells can be complemented by expression of the Ku80 cDNA, indicating that XRCC5 encodes Ku8O (18) . An involvement of DNA-PK in DNA double-strand break repair would be consistent with the fact that this enzyme requires DNA termini for its activation in vitro (1, 2, 4, 8, 25, 26) . We therefore wished to determine whether the kinase activity associated with DNA-PK is also impaired inxrs-6 cells. Here, we develop an assay scheme that can detect DNA-PK activity in extracts of rodent, Xenopus, and Drosophila cells and use this to determine DNA-PK levels inxrs-6 cell extracts. The results of these studies suggest that the DNA double-strand break repair and recombination defects of xrs-6 cells may be due not only to the loss of Ku DNA end binding activity but also to the concomitant loss of DNA-PK catalytic function.
MATERIALS AND METHODS
Cells, Extract Preparation, and Protein Purification. Mammalian cells, Xenopus laevis cell line XL-177, and their propagation were as described (22, 27) . Extracts were prepared by a modification of the method of Scholer et al. (28) : frozen cell pellets (0.5-3 x 107 cells) were resuspended in 100 ,ul of extraction buffer [50 mM NaF, 20 mM Hepes (pH 7.8), 450 mM NaCl, 25% (vol/vol) glycerol, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, leupeptin (0.5 ,tg/ml), protease inhibitor (0.5 ,ug/ml), trypsin inhibitor (1.0 ,ug/ml), aprotinin (0.5 ,ug/ml), bestatin (40 ,g/ml)] and then frozen on dry ice and thawed at 30°C three times. After microcentrifugation for 7 min at 4°C, supernatants were stored at -70°C. Ku was purified essentially as described (6) .
DNA-PK Assays. Standard peptide phosphorylation assays were as described (4). DNA-PK "pulldown" kinase assays were conducted as follows. Extract was incubated with 20 ,ul of preswollen double-stranded DNA (dsDNA)-cellulose (Sigma) in a total volume of 50 ,ul of Z'0.05 (25 mM Hepes/KOH at pH 7.9, 50 mM KCI, 10 mM MgCl2, 20% glycerol, 0.1% Nonidet P-40, 1 mM dithiothreitol). The dsDNA-cellulose was then washed twice with 1 added, and kinase assays were conducted in the presence or absence of 4 nmol of peptide (0.2 mM). Reactions were then stopped and analyzed by spotting onto phosphocellulose paper, washing, and subjecting to liquid scintillation counting as described (4) . The sequences of wild-type (wt) and mutant p53 peptides are EPPLSQEAFADLLKK and EPPLSE-QAFADLLKK, respectively. All assays were performed multiple times with at least two different extract preparations. Reproducibility of DNA-PK pulldown peptide assays (cpm incorporated for a given extract) is generally less than + 10%.
RESULTS
Standard DNA-PK Assays Do Not Detect DNA-PK in Rodent Cell Extracts. As Ku has been reported to be a component of DNA-PK, we wished to test whether DNA-PK activity is defective in xrs-6 cell extracts. The most sensitive DNA-PK assay hitherto described uses a synthetic peptide derived from the N-terminal transcriptional activation region of murine p53 (4) . In this assay, the peptide is incubated with DNA-PK and [y-32P]ATP, adsorbed onto derivatized paper, and peptide phosphorylation is determined by liquid scintillation counting after washing away unbound material. Generally, reactions are performed both in the absence and presence of DNA. Since DNA-PK appears to be the only DNA-activated kinase in mammalian cells (2, 4) , the difference of these two values provides a quantitative estimate of DNA-PK activity. As shown in Fig. 1 , using this method, DNA-activated peptide phosphorylation is detected readily using whole cell extract (WCE) from human 1BR cells. This kinase activity is indeed DNA-PK, because no DNA-activated phosphorylation is observed with a mutated peptide (MUT PEP) in which the DNA-PK phosphorylation site Ser-Gln is mutated to the sequence Ser-Glu, which is not recognized by DNA-PK (4, 11) . Consistent with previous reports (4), this standard assay does not detect DNA-PK activity in extracts of hamster or mouse cells (Fig. 1) .
Development of a DNA-PK Pulldown Peptide Assay. We considered it likely that DNA-PK would be present in rodents, because Ku homologs exist in mouse (29, 30) and Western blotting suggests that p350 is present in both murine and hamster cells (T.M.G. and S.P.J., unpublished data). Possible explanations for our inability to observe DNA-PK in rodent extracts were that its activity might be too low for detection or that its actions might be reversed by phosphatases. Thus, we reasoned that fractionation of rodent extracts might reveal DNA-PK activity. We therefore devised a microscale pulldown purification scheme for DNA-PK that takes advantage of the fact that this enzyme binds to dsDNA, whereas most protein phosphatases and kinases do not. In this assay, crude cell extract is incubated with dsDNA-cellulose, and then unbound material is removed by repeated washing. Because DNA-PK retains its activity when bound to DNA-cellulose, the immobilized enzyme is assayed simply by adding buffer, p53 peptide, and [y-32P]ATP. High levels of p53 peptide kinase activity are recovered from human cell extracts using this approach ( Fig.  2A) . Addition of more extract yields higher levels of recovered activity, and an approximately linear relationship exists between the amount of extract and kinase levels over a wide range of extract concentrations. Furthermore, the pulldown assay is effective both with crude nuclear extracts ( Fig. 2A ) and WCEs (Fig. 2B ). Since the recovered kinase is already DNA- bound, assays cannot be performed in the absence of DNA. Nevertheless, we conclude that the activity recovered is indeed DNA-PK, because the mutant p53 peptide is not phosphorylated significantly (Fig. 2B) .
Detection of DNA-PK Activity in Extracts of Hamster, (18) . The Ku80 gene maps to the human chromosome region 2q33-35 (24), and we have generated a series of hamster-human cell hybrids derived from xrs-6 cells that contain different portions of human DNA from this region (22, 23) . Some hybrids, such as H22 and D2-X-38, contain the Ku8O gene and complement the vrs-6 mutation, whereas others such as 38D do not contain an intact Ku80 gene and do not complement the mutation (18, 23) . When extracts from these clones were used in DNA-PK pulldown assays, we found that complementing hybrids H22 and D2-X-38 have DNA-PK activity, whereas noncomplementing hybrid 38D lacks detectable DNA-PK (Fig. 5A) . Kinase activity is consistently lower in hybrid D2-X-38 compared to hybrid H22, which correlates with the intermediate radiosensitivity of D2-X-38, which we have attributed to instability of the human DNA fragment in this line (18) . These results indicate that the defect in Ku8O inxrs-6 cells also results in a loss of DNA-PK activity.
Biochemical Complementation of xrs-6 Extracts with Purified Ku. If the DNA-PK defect of xrs-6 extracts is due solely to a lack of Ku, then the addition of purified Ku should restore DNA-PK activity. Previously, we have shown that p350 cannot bind DNA in the absence of Ku (8) and therefore anticipated that Ku would restore kinase activity only if added prior to the dsDNA-cellulose pulldown step. Consistent with this, when Ku is added to dsDNA-cellulose that has been preincubated with xrs-6 extracts, no complementation is achieved (data not shown). By contrast, when a purified preparation of Ku is mixed with the xrs-6 extract before adding the dsDNAcellulose, DNA-PK activity is obtained (Fig. SB) . We thus conclude that xrs-6 cells contain active p350 and that the DNA-PK defect is due to a specific deficiency in Ku.
DISCUSSION
In this paper, we describe an assay scheme for DNA-PK that employs a microscale DNA-PK pulldown purification on dsDNA-cellulose as its first step. This assay is much more sensitive than standard DNA-PK assays for several reasons.
First, the pulldown step can concentrate DNA-PK from dilute samples. Second (19, 20) . Thus, the DNA damage sensitivity profile of xrs-6 cells matches the fact that DNA-PK is activated in v7itro by dsDNA ends (1, 2, 4, 8) and suggests that DNA-PK functions in DNA repair by recognizing such structures. The observation that immunoglobulin V(D)J sitespecific recombination is also defective in xrs-6 cells additionally implicates DNA-PK in this process. Consistent with this, the V(D)J recombination defect of xrs-6 cells is not in generating site-specific DNA double-strand cuts but in subsequent steps that may overlap with the repair of dsDNA lesions that are generated by mutagenic agents (19) .
Our results raise the intriguing possibility that the p350 catalytic component of DNA-PK executes important functions Biochemistry: Finnie et al.
()()( Z in DNA repair and recombination. One way to verify this will be to determine whether mutants defective in p350 are impaired in DNA double-strand break repair. It will clearly be of great interest to determine whether p350 is defective in cell lines such as XR-1 and V3/scid, which are impaired in DNA double-strand break repair and V(D)J recombination but belong to different complementation groups from xrs-6 (refs. 33-35 and references therein). Unfortunately, the gene encoding p350 has not yet been cloned fully, and this is proving to be an arduous task since it is a large gene, which spans more than 100 kb of genomic DNA. There are several mechanisms (not necessarily mutually exclusive) by which DNA-PK may function in DNA repair and recombination. One is that the binding of Ku/DNA-PK to DNA termini protects them from nuclease digestion or assists in the alignment of two adjacent broken ends. In line with a role in protecting DNA ends from nucleases, the rare V(D)J recombination products that are generated in xrs-6 cells frequently bear large deletions, presumably as a result of nuclease attack (21) . Such DNA end protection could just require Ku but might also require the entire DNA-PK complex containing p350. Another possibility is that, when bound to DNA ends, DNA-PK phosphorylates and activates components of the DNA repair and recombination apparatus and thus restricts their activities to the appropriate cellular location. A third possibility is that DNA-PK enhances repair indirectly by phosphorylating and inactivating transcription factors to allow access by the repair and recombination machinery. Finally, it is possible that DNA-PK functions as a DNA-end sensor and that its activation initiates a signaling pathway to alert the cell to the fact that it has sustained DNA damage (36) . The availability of cell lines deficient in DNA-PK should prove extremely useful in examining these exciting possibilities.
